Search
for
Sort by
Research 151–180 of 299
- Resistance Training Ameliorates Finasteride-Induced Disturbance in Protein Homeostasis in Skeletal Muscle of Rats
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Finasteride
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Graphene oxide and indole-3-acetic acid cotreatment regulates the root growth of Brassica napus L. via multiple phytohormone pathways
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
- Hair follicle stem cell replication stress drives IFI16/STING-dependent inflammation in hidradenitis suppurativa
- Stability of polylactic acid particles and release of fluorochromes upon topical application on human skin explants
- Rare and common genetic determinants of metabolic individuality and their effects on human health
- Mechanical stress and the development of pseudo‐comedones and tunnels in Hidradenitis suppurativa/Acne inversa
- The expression of inducible nitric oxide synthase (iNOS) in the testis and epididymis of rats with a dihydrotestosterone (DHT) deficiency
- The Effect of the Aqueous Extract of Bidens Pilosa L. on Androgen Deficiency Dry Eye in Rats
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Herbal Therapy for the Treatment of Seborrhea Dermatitis
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- JAK inhibition decreases the autoimmune burden in Down syndrome
- The anti-inflammatory and analgesic activities of 2Br-Crebanine and Stephanine from Stephania yunnanenses H. S.Lo
- Serum Biotinidase Activity in Children Treated With Valproic Acid and Carbamazepine
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Prophylaxis and Management of Skin Toxicities
- Assessment of penetration of Ascorbyl Tetraisopalmitate into biological membranes by molecular dynamics
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme